For NFL, neurogranin, VILIP-1, YKL-40, and FABP3 levels in CSF and for NFL levels in blood, there is substantial evidence supporting their value as diagnostic and prognostic biomarkers in patients with AD. Here, NEFL is linked to Alzheimer disease.